Cuorips Inc.

4894・Growth Market・Pharmaceuticals

Official website

Cuorips Inc.

4894・Growth Market・Pharmaceuticals

Official website

Cuorips Inc.4894

Reference Indicators

Market Cap

385¥100M

P/E (Forecast)

—

P/B

8.2x

Dividend Yield (Forecast)

0.00%

ROE

-21.9%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	38	23	175	212
Cost of Sales	17	13	6	81
Gross Profit	21	9	168	130
SG&A Expenses	471	598	758	1,211
Operating Income	-450	-588	-590	-1,081
Non-operating Income	0	1	7	52
Non-operating Expenses	0	40	58	0
Ordinary Income	-450	-627	-642	-1,028
Extraordinary Income	0	1	—	1
Extraordinary Losses	—	3	—	—
Pre-tax Income	-449	-629	-642	-1,026
Income Taxes	2	2	3	3
Net Income	-452	-632	-644	-1,022
EBITDA	-371	-518	-513	-996
Gross Margin	54.9%	41.7%	96.0%	61.4%
Operating Margin	-1176.7%	-2547.3%	-336.9%	-509.2%
ROA	-12.6%	-10.2%	-11.2%	-20.0%
ROE	-13.2%	-10.6%	-11.8%	-21.9%